Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 289–296 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Alpha Tau Medical Ltd. Alpha DaRT - (IMPACT) Pancreatic ductal adenocarcinoma (PDAC) Phase 3 Intratumoral Oncology
Alpine Immune Sciences Inc. N91115 Cystic Fibrosis Phase 2 Trial Discontinued Oral Respiratory
Alpine Immune Sciences Inc. ALPN-303 - (DENALI) Systemic lupus erythematosus (SLE) Phase 2 Trial Planned subcutaneous Immunology
Alpine Immune Sciences Inc. Acazicolcept (ALPN-101) - (SYNERGY) Systemic Lupus Erythematosus (SLE) Phase 2 Ongoing Intravenous Immunology
Altamira Therapeutics Ltd. AM-125 - (TRAVERS) Vertigo Phase 2 Data Released intranasal Neurology
Alterity Therapeutics Limited ATH434-202 - (biomarker data) Multiple System Atrophy (MSA) Phase 2 Data Released Oral Neurology
Alterity Therapeutics Limited ATH434-201 Multiple System Atrophy (MSA) Phase 2 Data Released oral Neurology
Altimmune Inc. Pemvidutide - (RESTORE) Alcohol-Associated Liver Disease (ALD) Phase 2 Enrollment Initiation Subcutaneous Gastroenterology